Lung Cancer, Researchers In Bonn Are Laying The Foundation For A Future Blood Test
5/17/2011
A person's blood reveals whether he or she has lung cancer: this has been demonstrated by researchers at the University of Bonn. In collaboration with colleagues at the Cologne University Hospital, they are developing a blood test for smokers which could save human lives in the future, since the earlier a lung tumor is detected, the better the chances of survival are...
Individuals with a negative faecal test result at first screen (blood concentrations of less than 100 ng per mL) might be at increased risk of developing colorectal cancer in line with increasing faecal haemoglobin concentration...
Leucine Deprivation Proves Deadly To Malignant Melanoma Cells
5/16/2011
Whitehead Institute researchers have found that depriving human melanoma cells of the essential amino acid leucine can be lethal to the cells, suggesting a possible strategy for therapeutic intervention. The researchers observed the effect in melanoma cells with a mutation in the RAS/MEK signaling pathway-the most common mutation found in the deadliest form of skin cancer...
"Clot-Busters" No More Effective Than Traditional Therapy In Treating Lung Blood Clots
5/16/2011
Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs, a new study conducted by researchers in Spain and the U.S. indicates the agents do not appear to be any more effective than traditional blood thinners for the majority of these patients...
Study Reveals Need For Personalized Approach In Treatment Of AML
5/16/2011
A new discovery in mice by researchers at Wake Forest Baptist Medical Center may one day allow doctors to spare some patients with acute myeloid leukemia (AML) from toxic treatments, while also opening the door for new therapeutic research. AML, the most common form of acute leukemia seen in adults, is an aggressive form of cancer that primarily affects the elderly...
NewGene: New Genetics Test For Hereditary Breast Cancer Cuts Costs And Turnaround Times
5/16/2011
A new breakthrough test for hereditary breast cancer developed by UK-based NewGene could see thousands of women being diagnosed with the genetic condition in around half the usual time and at around half the cost of conventional test methods...
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food & Drug Administration (FDA) to begin clinical study of Ad-RTS-IL-12 (INXN 2001/1001), a novel DNA-based therapeutic candidate...
Solariums Emitting UV Six Times Stronger Than Midday Sun, Australia
5/16/2011
New research shows solarium users are being exposed to UV levels up to six times the strength of the midday sun and solarium operators are unaware of the excessive levels of UV radiation their customers are being exposed to. The research was conducted by Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), which measured UV emissions from solariums in Victoria and NSW...
Identifying Lung Cancer In Earliest Stages From Changes In Gene Expression In Nasal Cells
5/15/2011
A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest - and most treatable - stages, according to a study conducted by researchers in Boston. The study was presented at the ATS 2011 International Conference...
Unhealthy Substance Use A Risk Factor For Not Receiving Some Preventive Health Services
5/15/2011
Researchers from Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) have identified unhealthy substance use as a risk factor for not receiving all appropriate preventive health services. The findings, which currently appear in BMJ Open, identify unhealthy substance use as a barrier to completion of mammography screening and influenza vaccination...